Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
prostate drug
Marketing
Oncologists impressed with Novartis prostate cancer radiotherapy
Oncologists are impressed with Novartis' new radioligand therapy for prostate cancer but have concerns about treatment logistics, a survey found.
Natalie Missakian
Feb 23, 2022 7:10am
Texas says companies promote drugs without disclosing risks
Dec 14, 2021 4:00pm
Takeda guilty of breach of contract in partnership with AbbVie
Sep 23, 2021 11:13am
Ipsen campaign encourages men to discuss prostate cancer effects
Jun 8, 2021 11:31am
J&J ends bid for Erleada, Zytiga prostate cancer approval
Apr 20, 2021 12:18pm
Myovant leans on partner Pfizer as it dives into Orgovyx launch
Jan 25, 2021 3:15pm
